Evidence map›Paper›PMID 32365944›Full record

ArticleInternational journal of molecular sciences2020

SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.

Young-Sheng Chang, Bo-Han Ko, Jyh-Cherng Ju, Hsin-Hou Chang, Su-Hua Huang, Cheng-Wen Lin

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Immunity and Coagulation in COVID-19.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. The adaptation of SARS-CoV-2 to humans.Memorias do Instituto Oswaldo Cruz · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Standardized Extract ofMolecules (Basel, Switzerland) · 2021
    Article
  19. Article
  20. Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Young-Sheng ChangDepartment of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404394, Taiwan.
Bo-Han KoDepartment of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404394, Taiwan.
Jyh-Cherng JuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404394, Taiwan.
Hsin-Hou ChangDepartment of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970301, Taiwan.ORCID 0000-0002-8731-3485
Su-Hua HuangDepartment of Biotechnology, Asia University, Wufeng, Taichung 413305, Taiwan.
Cheng-Wen LinDepartment of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404394, Taiwan.ORCID 0000-0003-0165-2652
China Medical University · TWAsia University · TWTzu Chi University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) initiates the cytokine/chemokine storm-mediated lung injury. The SARS-CoV unique domain (SUD) with three macrodomains (N, M, and C), showing the G-quadruplex binding activity, was examined the possible role in SARS pathogenesis in this study. The chemokine profile analysis indicated that SARS-CoV SUD significantly up-regulated the expression of CXCL10, CCL5 and interleukin (IL)-1β in human lung epithelial cells and in the lung tissues of the mice intratracheally instilled with the recombinant plasmids. Among the SUD subdomains, SUD-MC substantially activated AP-1-mediated CXCL10 expression in vitro. In the wild type mice, SARS-CoV SUD-MC triggered the pulmonary infiltration of macrophages and monocytes, inducing CXCL10-mediated inflammatory responses and severe diffuse alveolar damage symptoms. Moreover, SUD-MC actuated NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome-dependent pulmonary inflammation, as confirmed by the NLRP3 inflammasome inhibitor and the NLRP3

Indexed as

AnimalsBronchoalveolar Lavage FluidCell LineChemokine CXCL10Disease Models, AnimalHumansInflammasomesLungMiceMice, Inbred C57BLMice, KnockoutMonocytesNLR Family, Pyrin Domain-Containing 3 ProteinPneumoniaPromoter Regions, GeneticSevere Acute Respiratory SyndromeChemokine CXCL10InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseViral ProteinsNLRP3 inflammasomepulmonary inflammationSARS-coronavirusSARS-CoV unique domain (SUD), CXCL10

Identifiers

PMID32365944
PMCPMC7247444
OpenAlexW3021275442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.